)
Edge17 Apr 2026
The New York Times Company: Adapting to the Times
How The New York Times Company built on a century-long legacy of trusted journalism to navigate disruption and reshape its business model.
Precipio
Precipio (PRPO) investor relations material
Precipio Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary2 Apr, 2026
Executive summary
Achieved transition to positive cash flow in 2025, marking a strategic inflection point.
Revenue grew 30% year-over-year to $24 million, driven by Pathology Services.
Shifted from capital preservation to growth initiatives and long-term value creation.
Financial highlights
Revenue reached $24 million in 2025, up 30% from 2024.
Overall gross margin improved from 41% in 2024 to 45% in 2025.
Pathology Services division drove most of the revenue and margin gains.
Products Division saw Q4 gross margin spike to 90% due to concentrated production, with a baseline margin of 50%.
All financial warrants exercised and Change Healthcare loan fully repaid, strengthening the balance sheet.
Outlook and guidance
Focus for 2026 is on accelerating growth in the Products Division and expanding market share.
Expect continued organic growth in Pathology Services and reinvestment of cash into Products.
Revenue mix anticipated to shift toward a more balanced split between Pathology Services and Products over the next 3–5 years.
Strategy to address Product sales fluctuations
Explain the 90% Q4 product margin sustainability
Competitive edge of the new rapid AML service
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Precipio
- Q2 2025 net sales up 27%, gross margin at 43%, with positive net income but ongoing risks.PRPO
Q2 202527 Jan 2026 - Q1 2025 revenue up 44% to $4.9M, gross margin 43%, net loss narrowed, but risks remain.PRPOQ1 202527 Jan 2026
- Q3 2025 saw 30% revenue growth, positive EBITDA, 44% margin, but going concern risk persists.PRPOQ3 202527 Jan 2026
- Net sales and pathology revenues rose, but losses and liquidity concerns remain.PRPOQ3 202427 Jan 2026
- Q2 2024 revenue up 26% to $4.4M, losses narrowed, but going concern risks remain.PRPOQ2 202427 Jan 2026
- Achieved Q4 break-even, strong revenue growth, and set ambitious 2025 expansion targets.PRPOQ4 202426 Dec 2025
- Annual meeting to elect directors, ratify auditor, and highlight board independence and ESG.PRPOProxy Filing1 Dec 2025
- Annual proxy covers director elections and key proposals, with no capital structure changes.PRPOProxy Filing1 Dec 2025
- Shareholders must vote promptly to ensure quorum and avoid costly meeting delays.PRPOProxy Filing1 Dec 2025
Next Precipio earnings date
Q1 202612 May, 2026
Precipio
Next Precipio earnings date
Q1 202612 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage